A women’s and children’s health technology fund has raised US$58m at its first close towards a target size of US$125m. Managed by Cross-Border Impact Ventures (CBIV),...
Despite incredible advances in medical science and digital innovation, a persistent and well-documented gender health gap continues to impact millions of women worldwide. From underfunded research...
By Annie Theriault, managing partner at Cross-Border Impact Ventures (CBIV)
By Annie Theriault, managing partner at Cross-Border Impact Ventures (CBIV)
By Annie Theriault, managing partner at Cross-Border Impact Ventures (CBIV)
Cross-Border Impact Ventures has made five investments to date in tech companies focused on women’s, children’s and adolescents’ health
Cambridge health tech company TidalSense has secured £14.2m in funding led by Cross-Border Impact Ventures to expand its AI-powered lung disease test across the NHS and...
Three leaders in menopause innovation have been shortlisted for a Femtech World Award. The Menopause Innovation of the Year award, sponsored by Cross-Border Impact Ventures (CBIV),...
If you are working in menopause care and have not yet entered the Femtech World Awards, you have until this Friday, 17 April, to put your...
The deadline to enter the third-annual Femtech World Awards has been extended by one month. The awards celebrates the brightest lights in women’s health innovation, with...
